By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Qiagen today said that its common stock has been added to the US large-cap Russell 1000 Index and the broad market Russell 3000 Index.

Russell Investments reconstituted its equity indexes after the close of the market on Friday, resulting in Qiagen's inclusion, the molecular diagnostics and sample prep technologies firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.